Skip to content

H.R. 5646 · 119th Congress (2025–2027)

Restoring Safeguards for Dangerous Abortion Drugs Act

To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 5646’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Mary E. Miller (R-IL-15)
Cosponsors
8 cosponsors

6 original · 2 later

8 R

  1. Rep. Tim Burchett (R-TN-2)· Original · Sep 30, 2025
  2. Rep. Sheri Biggs (R-SC-3)· Original · Sep 30, 2025
  3. Rep. Pat Harrigan (R-NC-10)· Original · Sep 30, 2025
  4. Rep. Doug LaMalfa (R-CA-1)· Original · Sep 30, 2025
  5. Rep. Barry Moore (R-AL-1)· Original · Sep 30, 2025
  6. Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Sep 30, 2025
  7. Rep. Michael Guest (R-MS-3)· Later · Oct 8, 2025
  8. Rep. Andy Harris (R-MD-1)· Later · Oct 31, 2025
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Sep 30, 2025
  2. HouseJudiciaryReferred Sep 30, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Restoring Safeguards for Dangerous Abortion Drugs Act

    Display title, Short title · Introduced in House

  2. To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.

    Official title · Introduced in House